Thomas Civik
Presidente en REPARE THERAPEUTICS INC. .
Fortuna: 91 135 $ al 30/04/2024
Cargos activos de Thomas Civik
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
REPARE THERAPEUTICS INC. | Presidente | 07/09/2021 | - |
Independent Dir/Board Member | 07/09/2021 | - | |
PYXIS ONCOLOGY, INC. | Director/Miembro de la Junta | 01/09/2021 | - |
Independent Dir/Board Member | 01/09/2021 | - | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Presidente | 23/03/2023 | - |
Independent Dir/Board Member | 23/03/2023 | - |
Historial de carrera de Thomas Civik
Antiguos cargos conocidos de Thomas Civik.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FIVE PRIME THERAPEUTICS, INC. | Director/Miembro de la Junta | 13/04/2020 | 16/04/2021 |
Director Ejecutivo | 13/04/2020 | 16/04/2021 | |
Presidente | 13/04/2020 | 16/04/2021 | |
FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/11/2017 | 01/09/2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Ventas & Marketing | - | - |
Formación de Thomas Civik.
Kellogg School of Management | Masters Business Admin |
St. Norbert College, Inc. | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Canadá | 2 |
Francia | 2 |
Operativa
Independent Dir/Board Member | 3 |
Director/Board Member | 2 |
Chairman | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
REPARE THERAPEUTICS INC. | Health Technology |
PYXIS ONCOLOGY, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Civik
- Experiencia